肾血管性高血压(RVH)是一种常见的继发性高血压,可通过外科手术和血管成形术得到矫正,主要靠肾动脉造影及数字减影式动脉造影来确诊,因其为创伤性检查,技木要求较复杂,临床应用受到一定限制,因此近年来不少学者力图探索出一种安全、可靠的技术用于检测肾血管疾病。巯甲丙脯酸(Captopril)是目前临床上广泛应用的新型抗高血压药物,应用其药物作用原理,有些学者对应用Captopril后血压及血浆肾素活性的变化进行了研究,并提出Captopril试验可用于鉴别肾血管性高血压。根据同样原理,该医学领域也应用Captopril试验以肾动态显像、肾图曲线及肾小球滤过率(GFR)对Captopril的反应来诊断RVH,它比普通肾动态显像、GFR测定提高了诊断的准确性,并提出疏甲丙脯酸试验可做为肾血管性高血压 Renal Vascular Hypertension (RVH) is a common secondary hypertension that can be corrected by surgery and angioplasty and is mainly diagnosed by renal angiography and digital subtraction angiography because it is traumatic In recent years, many scholars have tried to explore a safe and reliable technique for detecting renal vascular diseases. Captopril is a new type of antihypertensive drug widely used clinically. According to the principle of drug action, some scholars have studied the changes of blood pressure and plasma renin activity after applying Captopril, and proposed that Captopril test can be used In the identification of renal vascular hypertension. According to the same principle, the Captopril test is also used in the medical field to diagnose RVH by the dynamic renal imaging, the renalogram, and the glomerular filtration rate (GFR) response to Captopril, which is higher than normal renal dynamic imaging and GFR determination Diagnostic accuracy and raised apatis test can be used as renovascular hypertension